Eric J. Ende, Director at AVADEL PHARMACEUTICALS PLC (AVDL), bought 5,000 shares at $7.74 ($39K) on 2020-08-13, disclosed to the SEC on 2020-08-17.
Open-market purchase of $39k AVDL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.74 | 1,200 | $9K | 23.9% |
| 2 | $7.80 | 3,800 | $30K | 76.1% |
| Total | $7.79 avg | 5,000 | $39K | 100% |
| Filing → |
| AVDL | BUY | 2022-11-23 | $156K | — | Filing → |
| AVDL | BUY | 2022-06-01 | $78K | — | Filing → |
| AVDL | BUY | 2022-05-31 | $37K | — | Filing → |